NP33922 Ranibizumab

{
  "id": "015999-2022",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 2,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 1,
        "measure": "smeBids",
        "relatedLot": "1"
      },
      {
        "id": "3",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "1"
      },
      {
        "id": "4",
        "value": 2,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1"
      },
      {
        "id": "5",
        "value": 2,
        "measure": "electronicBids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2022-06-10T13:11:45+01:00",
  "ocid": "ocds-h6vhtk-031a43",
  "buyer": {
    "id": "GB-FTS-322",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
  },
  "links": [
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000682929"
    }
  ],
  "awards": [
    {
      "id": "015999-2022-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-3471",
          "name": "Teva UK Limited"
        },
        {
          "id": "GB-FTS-4556",
          "name": "Novartis Pharmaceuticals UK Ltd"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "ocds-h6vhtk-031a43",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes and ranibizumab 2.3mg/0.23ml solution for injection vials to NHS Scotland.\nThe Authority has awarded this framework as an unranked multi-supplier framework per line to two (2) Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Supply Chain",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "NP33922 Ranibizumab",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "Supply of ranibizumab injections to NHS Scotland.",
    "reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has be entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-322",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
      },
      "contactPoint": {
        "email": "stephanie.mcniven2@nhs.scot",
        "telephone": "+44 1698794410"
      }
    },
    {
      "id": "GB-FTS-3471",
      "name": "Teva UK Limited",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Castleford",
        "postalCode": "WF10 5HX",
        "countryName": "United Kingdom",
        "streetAddress": "Ridings Point, Whistler Drive"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Teva UK Limited"
      },
      "contactPoint": {
        "faxNumber": "+44 1977628788",
        "telephone": "+44 7715800199"
      }
    },
    {
      "id": "GB-FTS-4556",
      "name": "Novartis Pharmaceuticals UK Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Frimley",
        "postalCode": "GU16 7SR",
        "countryName": "United Kingdom",
        "streetAddress": "Frimley Business Park, Frimley, Surrey"
      },
      "details": {
        "scale": "sme"
      },
      "identifier": {
        "legalName": "Novartis Pharmaceuticals UK Ltd"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "details": {
        "url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk",
        "telephone": "+44 1312252525"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "015999-2022-1",
      "value": {
        "amount": 11706517,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "015999-2022-1",
      "dateSigned": "2022-05-13T00:00:00+01:00"
    }
  ],
  "description": "The estimated value(s) referred to in Section II.I.7 and, Section V.2.4  covers the nine (9) month contract duration and the thirty-six (36) month extension period of the framework agreement.\n(SC Ref:696391)",
  "initiationType": "tender"
}

{
  "id": "005031-2022",
  "tag": [
    "tender"
  ],
  "date": "2022-02-23T09:15:02Z",
  "ocid": "ocds-h6vhtk-031a43",
  "buyer": {
    "id": "GB-FTS-322",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
  },
  "links": [
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000682929"
    }
  ],
  "tender": {
    "id": "ocds-h6vhtk-031a43",
    "lots": [
      {
        "id": "1",
        "value": {
          "amount": 15810833,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for period(s) up to a total period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes and ranibizumab 2.3mg/0.23ml solution for injection vials to NHS Scotland.  The Authority intends to award this framework as an unranked multi-supplier framework per line to a maximum of three (3) Framework Participants per line.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Supply Chain",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 270
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "NP33922 Ranibizumab",
    "value": {
      "amount": 15810833,
      "currency": "GBP"
    },
    "status": "active",
    "coveredBy": [
      "GPA"
    ],
    "bidOpening": {
      "date": "2022-03-25T12:00:00Z"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "techniques": {
      "frameworkAgreement": {
        "maximumParticipants": 3
      },
      "hasFrameworkAgreement": true
    },
    "awardPeriod": {
      "startDate": "2022-03-25T12:00:00Z"
    },
    "description": "Supply of ranibizumab injections to NHS Scotland.",
    "tenderPeriod": {
      "endDate": "2022-03-25T12:00:00Z"
    },
    "contractTerms": {
      "hasElectronicPayment": true,
      "hasElectronicOrdering": true,
      "electronicInvoicingPolicy": "allowed"
    },
    "hasRecurrence": false,
    "reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful.  The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement.  The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition.  The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s).  The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established.  Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ]
    },
    "submissionMethod": [
      "electronicSubmission"
    ],
    "procurementMethod": "open",
    "selectionCriteria": {
      "criteria": [
        {
          "type": "suitability",
          "appliesTo": [
            "supplier"
          ],
          "description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
        },
        {
          "type": "technical",
          "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.\n(c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.",
          "appliesTo": [
            "supplier"
          ],
          "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.\n(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.\n(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design."
        }
      ]
    },
    "mainProcurementCategory": "goods",
    "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-322",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
      },
      "contactPoint": {
        "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "email": "stephanie.mcniven2@nhs.scot",
        "telephone": "+44 1698794410"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "details": {
        "url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk",
        "telephone": "+44 1312252525"
      }
    }
  ],
  "language": "en",
  "description": "The estimated value referred to in Section II.1.5 and II.2.6 covers the nine (9) month initial duration and the thirty six (36) month extension period of the framework agreement.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 20773. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nThe Statement of Requirements will detail the Community Benefit background and objectives. The contract will mandate that suppliers\nrespond in its tender outlining current Community Benefits and proposals if successful and mandating that they support the overall Community Benefit concept and process including a contract and supplier management process post award.\n(SC Ref:682929)",
  "initiationType": "tender"
}